Chemoinformaics analysis of Sarmentologenin [German]
| Molecular Weight | 422.518 | nRot | 2 |
| Heavy Atom Molecular Weight | 388.246 | nRig | 25 |
| Exact Molecular Weight | 422.23 | nRing | 5 |
| Solubility: LogS | -2.609 | nHRing | 1 |
| Solubility: LogP | 0.593 | No. of Aliphatic Rings | 5 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 64 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 30 | No. of Aromatic Carbocycles | 0 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 23 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 0 |
| nHA | 7 | APOL | 66.695 |
| nHD | 5 | BPOL | 36.713 |
| QED | 0.427 |
| Synth | 5.237 |
| Natural Product Likeliness | 2.814 |
| NR-PPAR-gamma | 0.221 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.998 |
| HIA | 0.288 |
| CACO-2 | -6.114 |
| MDCK | 0.0000386 |
| BBB | 0.505 |
| PPB | 0.872193 |
| VDSS | 0.65 |
| FU | 0.162995 |
| CYP1A2-inh | 0.007 |
| CYP1A2-sub | 0.71 |
| CYP2c19-inh | 0.006 |
| CYP2c19-sub | 0.277 |
| CYP2c9-inh | 0.017 |
| CYP2c9-sub | 0.121 |
| CYP2d6-inh | 0.002 |
| CYP2d6-sub | 0.097 |
| CYP3a4-inh | 0.293 |
| CYP3a4-sub | 0.123 |
| CL | 5.769 |
| T12 | 0.489 |
| hERG | 0.075 |
| Ames | 0.016 |
| ROA | 0.938 |
| SkinSen | 0.366 |
| Carcinogencity | 0.929 |
| EI | 0.02 |
| Respiratory | 0.958 |
| NR-Aromatase | 0.899 |
| Antiviral | Yes |
| Prediction | 0.712085 |